Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 8.


Davison, AS, Norman, B, Milan, AM, Hughes, AT, Khedr, M ORCID: 0000-0002-4998-2397, Rovensky, J, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR
(2018) Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment. JIMD reports, 41. 1 - 10.


Khedr, M ORCID: 0000-0002-4998-2397, Judd, S, Briggs, MC, Hughes, AT, Milan, AM, Stewart, RMK, Lock, EA, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR
(2018) Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria. JIMD reports, 40. 31 - 37.


Davison, AS ORCID: 0000-0001-5501-4475, Harrold, JA ORCID: 0000-0002-0899-4586, Hughes, G, Norman, B ORCID: 0000-0001-9293-4852, Devine, J, Usher, J, Hughes, AT, Khedr, M ORCID: 0000-0002-4998-2397, Gallagher, JA ORCID: 0000-0002-0852-279X, Milan, AM ORCID: 0000-0002-0452-2338
et al (show 2 more authors) (2018) Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinone. Molecular Genetics and Metabolism, 125 (1-2). 135 - 143.


Griffin, R ORCID: 0000-0003-4521-948X, Psarelli, EE ORCID: 0000-0002-3102-0288, Cox, TF, Khedr, M ORCID: 0000-0002-4998-2397, Milan, AM ORCID: 0000-0002-0452-2338, Davison, AS ORCID: 0000-0001-5501-4475, Hughes, AT, Usher, JL, Taylor, S, Loftus, N
et al (show 17 more authors) (2018) Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinone. Data in Brief, 20. 1620 - 1628.


Ranganath, LR, Khedr, M ORCID: 0000-0002-4998-2397, Milan, AM ORCID: 0000-0002-0452-2338, Davison, AS ORCID: 0000-0001-5501-4475, Hughes, AT, Usher, JL, Taylor, S, Loftus, N, Daroszewska, A ORCID: 0000-0002-6692-6610, West, E
et al (show 17 more authors) (2018) Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre. Molecular genetics and metabolism, 125 (1-2). 127 - 134.


Milan, AM ORCID: 0000-0002-0452-2338, Hughes, AT, Davison, AS ORCID: 0000-0001-5501-4475, Khedr, M ORCID: 0000-0002-4998-2397, Rovensky, J, Psarelli, EE ORCID: 0000-0002-3102-0288, Cox, TF, Rhodes, NP ORCID: 0000-0002-5173-7032, Gallagher, JA and Ranganath, LR
(2019) Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria. SCIENTIFIC REPORTS, 9.


Davison, AS, Norman, BP, Smith, EA, Devine, J, Usher, J, Hughes, AT, Khedr, M ORCID: 0000-0002-4998-2397, Milan, AM, Gallagher, JA ORCID: 0000-0002-0852-279X and Ranganath, LR
(2018) Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone. JIMD reports, 41. 109 - 117.


Cox, T, Psarelli, EE ORCID: 0000-0002-3102-0288, Taylor, S, Shepherd, HR, Robinson, M, Barton, G, Mistry, A, Genovese, F, Braconi, D, Giustarini, D
et al (show 12 more authors) (2019) Subclinical ochronosis features in alkaptonuria: A cross-sectional study. BMJ Innovations.

This list was generated on Thu Nov 26 20:53:42 2020 GMT.